Effects of β-glucan and Vitamin D Supplementation on Inflammatory Parameters in Patients with Diabetic Retinopathy

References

• Alcubierre N, Valls J, Rubinat E, Cao G, Esquerda A, Traveset A, Granado-Casas M, Jurjo C, Mauricio D. 2015. Vitamin D deficiency is associated with the presence and severity of diabetic retinopathy in Type 2 diabetes mellitus. J Diabetes Res. 2015:374178. PMID:26078978.
   PubMed Web of Science ®Google Scholar
• Andrade-Oliveira V, Camara NO, Moraes-Vieira PM. 2015. Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res. 2015:681612. PMID:25918733.
   PubMed Web of Science ®Google Scholar
• Bajaj S, Singh RP, Dwivedi NC, Singh K, Gupta A, Mathur M. 2014. Vitamin D levels and microvascular complications in type 2 diabetes. Indian J Endocrinol Metab. 18:537–541. doi:10.4103/2230-8210.137512. PMID:25143913.
   PubMedGoogle Scholar
• Bonakdaran S, Shoeibi N. 2015. Is there any correlation between vitamin D insufficiency and diabetic retinopathy? Int J Ophthalmol. 8:326–31. PMID:25938050
   PubMed Web of Science ®Google Scholar
• Čapková N, Lustigová M, Kratěnová J. 2017. [Selected population health indicators in the Czech Republic-EHES 2014]. Hygiena. 62:35–37. doi:10.21101/hygiena.a1511.
   Google Scholar
• Cloetens L, Ulmius M, Johansson-Persson A, Akesson B, Onning G. 2012. Role of dietary beta-glucans in the prevention of the metabolic syndrome. Nutr Rev. 70:444–458. doi:10.1111/j.1753-4887.2012.00494.x. PMID:22835138.
   PubMed Web of Science ®Google Scholar
• Coppari R, Bjorbaek C. 2012. Leptin revisited: Its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov. 11:692–708. doi:10.1038/nrd3757. PMID:22935803.
   PubMed Web of Science ®Google Scholar
• El Khoury D, Cuda C, Luhovyy BL, Anderson GH. 2012. Beta glucan: Health benefits in obesity and metabolic syndrome. J Nutr Metab. 2012:851362. doi:10.1155/2012/851362. PMID:22187640.
   PubMedGoogle Scholar
• Galisteo M, Duarte J, Zarzuelo A. 2008. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 19:71–84. doi:10.1016/j.jnutbio.2007.02.009. PMID:17618108.
   PubMed Web of Science ®Google Scholar
• Garcia-Bailo B, El-Sohemy A, Haddad PS, Arora P, Benzaied F, Karmali M, Badawi A. 2011. Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: Modulation of inflammation and oxidative stress. Biologics. 5:7–19. PMID:21383912.
   PubMedGoogle Scholar
• Gruys E, Toussaint MJ, Niewold TA. 2005. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 6:1045–1056. doi:10.1631/jzus.2005.B1045. PMID:16252337.
   PubMedGoogle Scholar
• Hood KK, Beavers DP, Yi-Frazier J, Bell R, Dabelea D, Mckeown RE, Lawrence JM. 2014. Psychosocial burden and glycemic control during the first 6 years of diabetes: Results from the search for Diabetes in Youth study. J Adolesc Health. 55:498–504. doi:10.1016/j.jadohealth.2014.03.011. PMID:24815959.
   PubMed Web of Science ®Google Scholar
• Hood KK, Lawrence JM, Anderson A, Bell R, Dabelea D, Daniels S, Rodriguez B, Dolan LM, SEARCH for Diabetes in Youth Study Group. 2012. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care. 35:2443–2446. doi:10.2337/dc11-2329. PMID:23033243.
   PubMed Web of Science ®Google Scholar
• Lee R, Wong TY, Sabanayagam C. 2015. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2:17. doi:10.1186/s40662-015-0026-2. PMID:26605370.
   PubMedGoogle Scholar
• Luo BA, Gao F, Qin LL. 2017. The association between vitamin D deficiency and diabetic retinopathy in type 2 diabetes: A meta-analysis of observational studies. Nutrients. 9:307, doi:10.3390/nu9030307.
   Web of Science ®Google Scholar
• Luttrull JK, Dorin G. 2012. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: A review. Curr Diabetes Rev. 8:274–284. doi:10.2174/157339912800840523. PMID:22587512.
   PubMedGoogle Scholar
• Marzi C, Huth C, Herder C, Baumert J, Thorand B, Rathmann W, Wichmann HE, Roden M, Peters A, Grallert H, Koenig W, Illig T. 2013. Acute-phase serum amyloid a protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care. 36:1321–1326. doi:10.2337/dc12-1514. PMID:23238662.
   PubMed Web of Science ®Google Scholar
• Meek TH, Morton GJ. 2016. The role of leptin in diabetes: Metabolic effects. Diabetologia. 59:928–932. doi:10.1007/s00125-016-3898-3. PMID:26969486.
   PubMed Web of Science ®Google Scholar
• Mehmood ZH, Papandreou D. 2016. An updated mini review of vitamin D and obesity: Adipogenesis and inflammation state. Open Access Maced J Med Sci. 4:526–532. doi:10.3889/oamjms.2016.103. PMID:27703587.
   PubMedGoogle Scholar
• Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris F, Chew EY. 2005. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci. 46:4295–4301. doi:10.1167/iovs.04-1057. PMID:16249511.
   PubMed Web of Science ®Google Scholar
• Mousa A, Misso M, Teede H, Scragg R, de Courten B. 2016. Effect of vitamin D supplementation on inflammation: Protocol for a systematic review. BMJ Open. 6:e010804. doi:10.1136/bmjopen-2015-010804. PMID:27048637.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Yokoyama K, Yokoo T, Urashima M. 2016. Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes. 7:89–100. doi:10.4239/wjd.v7.i5.89. PMID:26981182.
   PubMed Web of Science ®Google Scholar
• Naylor C, Petri WA, Jr. 2016. Leptin regulation of immune responses. Trends Mol Med. 22:88–98. doi:10.1016/j.molmed.2015.12.001. PMID:26776093.
   PubMed Web of Science ®Google Scholar
• Nita M, Grzybowski A, Ascaso FJ, Huerva V. 2014. Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). Mediators Inflamm. 2014:930671. doi:10.1155/2014/930671. PMID:25214719.
   PubMed Web of Science ®Google Scholar
• Pickup JC. 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 27:813–823. doi:10.2337/diacare.27.3.813. PMID:14988310.
   PubMed Web of Science ®Google Scholar
• Rabenberg M, Scheidt-Nave C, Busch MA, Rieckmann N, Hintzpeter B, Mensink GB. 2015. Vitamin D status among adults in germany–results from the german health interview and examination survey for adults (DEGS1). BMC Public Health. 15:641. doi:10.1186/s12889-015-2016-7. PMID:26162848.
   PubMed Web of Science ®Google Scholar
• Rebello CJ, Burton J, Heiman M, Greenway FL. 2015. Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: A randomized controlled pilot trial. J Diabetes Complications. 29:1272–1276. doi:10.1016/j.jdiacomp.2015.08.023. PMID:26424589.
   PubMed Web of Science ®Google Scholar
• Richter J, Kral V, Stiborova I, Rajnohova L, Vetvicka V. 2015. Anti-inflammatory effects of beta-glucan in cancer related fatigue. J Nutr Health Sci. 2:304.
   Google Scholar
• Richter J, Kral V, Vetvicka V, Rajnohova Dobiasova L, Fernandez-Botran R. 2016. Effect of beta-glucan supplementation on levels of IgM, IgA, IgG and its subclasses IgG1, IgG2, IgG3, and IgG4 in cancer patients. J Tumor. 4:469–473. doi:10.17554/j.issn.1819-6187.2016.04.98.
   Google Scholar
• Roy MS, Janal MN, Crosby J, Donnelly R. 2013. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci. 54:5471–5480. doi:10.1167/iovs.13-12212. PMID:23847308
   PubMed Web of Science ®Google Scholar
• Semeraro F, Cancarini A, dell'Omo R, Rezzola S, Romano MR, Costagliola C. 2015. Diabetic retinopathy: Vascular and inflammatory disease. J Diabetes Res. 2015:582060. doi:10.1155/2015/582060. PMID:26137497.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW. 2017. Diabetic retinopathy: A position statement by the American Diabetes Association. Diabetes Care. 40:412–418. doi:10.2337/dc16-2641. PMID:28223445.
   PubMed Web of Science ®Google Scholar
• Stier H, Ebbeskotte V, Gruenwald J. 2014. Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan. Nutr J. 13:38. doi:10.1186/1475-2891-13-38. PMID:24774968.
   PubMed Web of Science ®Google Scholar
• Talbott SM, Talbott JA. 2012. Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women. J Am Coll Nutr. 31:295–300. doi:10.1080/07315724.2012.10720441. PMID:23378458.
   PubMed Web of Science ®Google Scholar
• Vetvicka V, Vetvickova J. 2016. Addition of selenium improves immunomodulative effects of glucan. N Am J Med Sci. 8:88–92. doi:10.4103/1947-2714.177311. PMID:27042606.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ames NP, Tun HM, Tosh SM, Jones PJ, Khafipour E. 2016. High molecular weight barley beta-glucan alters gut microbiota toward reduced cardiovascular disease risk. Front Microbiol. 7:129. PMID:26904005.
   PubMed Web of Science ®Google Scholar